Table 3
Clinicopathological data of group 4 patients (patients with colorectal carcinoma)
| Variable | Number |
|---|---|
| IHC, immunohistochemistry. | |
| Patients with IHC scores >300 (n = 25) | |
| Sex | |
| Male | 16 |
| Female | 9 |
| Age (years) | |
| Range | 36–84 |
| Median | 63.6 |
| TNM tumour stage | |
| T1 | 3 |
| T2 | 6 |
| T3 | 11 |
| T4 | 5 |
| TNM lymph node status | |
| N0 | 6 |
| N1 | 16 |
| N2 | 3 |
| Degree of differentiation | |
| Well | 0 |
| Moderate | 16 |
| Poor | 9 |
| Patients with IHC scores <150 (n = 18) | |
| Sex | |
| Male | 13 |
| Female | 5 |
| Age (years) | |
| Range | 31–75 |
| Median | 57.9 |
| TNM tumour stage | |
| T1 | 3 |
| T2 | 8 |
| T3 | 5 |
| T4 | 2 |
| TNM lymph node status | |
| N0 | 15 |
| N1 | 2 |
| N2 | 1 |
| Degree of differentiation | |
| Well | 0 |
| Moderate | 13 |
| Poor | 5 |
